Dr. Thomas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3619 Park East Dr
Ste 306
Beachwood, OH 44122Phone+1 216-292-9150Fax+1 216-292-9159
Education & Training
- Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Cataract and Refracrive Surgery, 1996 - 1997
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Ophthalmology, 1993 - 1996
- University of HawaiiInternship, Transitional Year, 1992 - 1993
- Case Western Reserve University School of MedicineClass of 1992
Certifications & Licensure
- OH State Medical License 1996 - 2025
- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 10 citationsThe Drosophila hep pathway mediates Lrrk2-induced neurodegenerationDejun Yang, Joseph M. Thomas, Tianxia Li, Youngseok Lee, Zhaohui Liu
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 2018-08-01 - 19 citationsSynphilin-1 attenuates mutant LRRK2-induced neurodegeneration in Parkinson's disease modelsJingnan Liu, Tianxia Li, Joseph M. Thomas, Zhong Pei, Haibing Jiang
Human Molecular Genetics. 2016-02-15 - 40 citationsA novel GTP-binding inhibitor, FX2149, attenuates LRRK2 toxicity in Parkinson's disease models.Tianxia Li, Xinhua He, Joseph M. Thomas, Dejun Yang, Shijun Zhong
Plos One. 2015-03-27
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: